• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CluePoints appoints Steve Young as senior vice president of U.S. operations

CluePoints appoints Steve Young as senior vice president of U.S. operations

August 23, 2016
CenterWatch Staff

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has appointed Steve Young as senior vice president of its U.S. Operations. The appointment marks a key strategic move for the company in optimizing its operational performance, customer support and service delivery across North America.

Young will oversee all U.S. sponsor deliverables including software implementation, professional services, and RBM process consultancy. He will also take responsibility for customer success planning and execution, including working closely with clients to further enhance the use of CluePoints’ Central Statistical Monitoring platform within their organizations.

With a career in clinical research spanning more than 20 years, Young brings unrivaled specialist knowledge to CluePoints, having worked on the sponsor side for J&J, Centocor, Astra-Merck and most recently as senior director of Transformation Services for OmniComm Systems, where he was responsible for overseeing and delivering advanced RBM services for clients.

“We are delighted to welcome Steve Young to our team,” said CluePoints’ CEO, Franҫois Torche. “With more and more CROs and BioPharma sponsors embarking on a knowledge transfer process to enable them to be self-sufficient in using RBM software, we are continuously looking to bring the highest level of expertise to our team to ensure our clients have the support and guidance they need during this process.”

“Steve’s experience and reputation within the sector make him the ideal person for this newly established position within CluePoints, and having already worked closely with Steve for a number of years in his previous role, I am confident that he will achieve great success as part of the CluePoints team. Many sponsors look to CluePoints, not only to provide them with THE enabling technology for Risk-Based Monitoring, but also to advise how they should change their internal process to get the best out of their technology choice. We now have the perfect industry Thought Leader to enhance that consultative discussion.”

Commenting on his appointment, Steve Young said, “CluePoints has a fantastic reputation and is at the forefront of RBM, helping some of the most recognized names in the industry to integrate the approach seamlessly into their workflow. I’m very much looking forward to being part of the team and helping CluePoints continue its impressive journey.”

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing